/
Pharmaceutical preparations company · DE · FY ends Dec · -623.62% margin
The business is unprofitable at the operating level (-623.62% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 85.7% YoY with margins expanding 376.6pp.
Negative free cash flow of -$77M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$13M
▲ +85.7% YoY
Net Income (TTM)
-$75M
▼ -3.1% YoY
Op. Margin
-623.62%
▲ +376.6pp YoY
ROIC
-51.17%
▲ +5350.6pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-$77M
▼ -31.6% YoY
Op. Cash Flow (FY)
-$76M
▼ -31.4% YoY
Net Debt
-$202M
Net Cash Position
Cash & Equiv.
$211M
Continue Research